Total knee replacement

Kane RL, Saleh KJ, Wilt TJ, Bershadsky B, Cross WW III, MacDonald RM, Rutks I
Record ID 32004000094
English
Authors' objectives:

A systematic review of the literature was undertaken to address the following questions: - What are the current indications for, and outcomes from, primary total knee replacement?

- How do specific characteristics of the patient, material and design of the prosthesis, and surgical factors, affect the short-term and long-term outcomes of primary total knee replacement?

- Are there important perioperative interventions that influence outcomes?

- What are the indications, approaches, and outcomes for revision total knee replacement?

- What factors explain disparities in the utilization of total knee replacement in different populations?

- What are the directions for future research?

Authors' results and conclusions: Both total knee arthroplasty (TKA) and total knee arthroplasty revision (TKAR) are associated with improved function. The strongest evidence exists over a followup period of up to two years, but the studies that extend to five and even ten years of followup show positive results as well. The average age of patients undergoing TKA in these reports was 70 years with few over aged 85. Two -thirds were female, one third were considered obese, and nearly 90% had osteoarthritis. No studies provided data on racial/ethnic status. The mean effect size (expressed as numbers of standard deviations) is considered large in magnitude and varies from 1.6 to 3.9 depending on the functional measure used and the duration of followup. There is no evidence that age, gender, or obesity are strong predictors of functional outcomes. Patients with rheumatoid arthritis show more improvement than those with osteoarthritis, but this may be related to their poorer functional scores at the time of treatment and hence the potential for more improvement. The revision rate through five or more years is 2.0% of knees and 2.1% of patients. Complications as defined by the investigator occurred in 5.4% of patients and 7.6% of knees. Patients with rheumatoid arthritis show more improvement than those with osteoarthritis. With regard to access, nonwhites receive TKAs less often than whites despite higher rates of osteoarthritis. Women receive TKAs more often than men, but the pattern is not as consistent as with race. TKA revisions are associated with consistent improvement in function on an order of magnitude similar to primary TKAs.
Authors' recommendations: In general, the outcomes research on TKAs emphasizes before and after studies that are variations on case series of various techniques and prostheses with little attention to the role of other factors or to attrition. Although demographic and clinical factors are recorded, they are rarely used in the analysis. A consistent body of evidence suggests substantial improvement in function associated with TKA and TKAR. The follow-up periods vary but the mean is greater than five years. More informed decision making about indicators for TKAs will require stronger research designs. These need to be planned as prospective studies with multivariate analysis. Such analyses will require larger samples and more consistent and comprehensive data collection than was found in this review.
Authors' methods: Systematic review
Details
Project Status: Completed
Year Published: 2003
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Arthritis
  • Arthroplasty, Replacement, Knee
  • Knee Joint
Contact
Organisation Name: Agency for Healthcare Research and Quality
Contact Address: Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name: martin.erlichman@ahrq.hhs.gov
Contact Email: martin.erlichman@ahrq.hhs.gov
Copyright: Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.